These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22494993)

  • 1. Different effects of AT1 receptor antagonist and ET(A) receptor antagonist on ischemia-induced norepinephrine release in rat hearts.
    Fukumoto T; Tawa M; Kitada K; Yamashita N; Ohkita M; Okamura T; Matsumura Y
    J Cardiovasc Pharmacol; 2012 Jul; 60(1):55-60. PubMed ID: 22494993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different contributions of endothelin-A and endothelin-B receptors in postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
    Yamamoto S; Matsumoto N; Kanazawa M; Fujita M; Takaoka M; Gariepy CE; Yanagisawa M; Matsumura Y
    Circulation; 2005 Jan; 111(3):302-9. PubMed ID: 15642760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of exogenous big endothelin-1 on postischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
    Tawa M; Fukumoto T; Ohkita M; Yamashita N; Geddawy A; Imamura T; Ayajiki K; Okamura T; Matsumura Y
    Hypertens Res; 2011 Feb; 34(2):218-24. PubMed ID: 21048781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ET(A) and ET(B) receptor blockade on post-ischemic cardiac dysfunction and norepinephrine overflow in isolated rat hearts.
    Yamamoto S; Matsumoto N; Kanazawa M; Fujita M; Takaoka M; Matsumura Y
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S394-7. PubMed ID: 15838330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endogenous endothelin-1 in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts.
    Tawa M; Fukumoto T; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2008 Sep; 591(1-3):182-8. PubMed ID: 18586023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the angiotensin AT1 receptor blocker candesartan on myocardial ischemic/reperfusion injury.
    Shimizu M; Sjöquist PO; Wang QD; Rydén L
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S137-42. PubMed ID: 9892154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of 17beta-estradiol on post-ischemic cardiac dysfunction and norepinephrine overflow through the non-genomic estrogen receptor/nitric oxide-mediated pathway in the rat heart.
    Fukumoto T; Tawa M; Yamashita N; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2013 Jan; 699(1-3):74-80. PubMed ID: 23219795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
    Wang QD; Sjöquist PO
    Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postconditioning improves postischemic cardiac dysfunction independently of norepinephrine overflow after reperfusion in rat hearts: comparison with preconditioning.
    Tawa M; Fukumoto T; Yamashita N; Ohkita M; Ayajiki K; Okamura T; Matsumura Y
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):6-13. PubMed ID: 19786893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in postischemic cardiac dysfunction and norepinephrine overflow in rat heart: the role of estrogen against myocardial ischemia-reperfusion damage via an NO-mediated mechanism.
    Fukumoto T; Yamashita N; Tawa M; Ohkita M; Matsumura Y
    J Cardiovasc Pharmacol; 2012 Sep; 60(3):269-75. PubMed ID: 22635075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the AT1 receptor blocker candesartan on myocardial ischemia/reperfusion in isolated rat hearts.
    Songur CM; Songur MO; Kocabeyoglu SS; Basgut B
    Heart Surg Forum; 2014 Oct; 17(5):E263-8. PubMed ID: 25367240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
    Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts.
    Hatta E; Maruyama R; Marshall SJ; Imamura M; Levi R
    J Pharmacol Exp Ther; 1999 Mar; 288(3):919-27. PubMed ID: 10027827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of nitric oxide in big endothelin-1-induced cardioprotective effects on ischemia/reperfusion injury in rat hearts.
    Tawa M; Fukumoto T; Ohkita M; Yamashita N; Geddawy A; Imamura T; Ayajiki K; Okamura T; Matsumura Y
    J Cardiovasc Pharmacol; 2011 May; 57(5):575-8. PubMed ID: 21326108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ACE-inhibitor ramiprilat and AT1-receptor antagonist candesartan on cardiac norepinephrine release: comparison between ischemic and nonischemic conditions.
    Richardt D; Wolfrum S; Büttner C; Schäfer U; Dendorfer A; Kurz T; Richardt G
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):641-6. PubMed ID: 12352328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased AT(2)R protein expression but not increased apoptosis during cardioprotection induced by AT(1)R blockade.
    Moudgil R; Musat-Marcu S; Xu Y; Kumar D; Jugdutt BI
    Can J Cardiol; 2002 Oct; 18(10):1107-16. PubMed ID: 12420045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
    Sasaoka T; Egi Y; Tawa M; Yamamoto A; Ohkita M; Takaoka M; Maruyama T; Akira T; Matsumura Y
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):176-83. PubMed ID: 18670361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased AT2R protein expression but not increased apoptosis during cardioprotection induced by AT1R blockade.
    Moudgil R; Musat-Marcu S; Xu Y; Kumar D; Jugdutt BI
    Can J Cardiol; 2002 Aug; 18(8):873-83. PubMed ID: 12215750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels.
    Fujita T; Hirooka K; Nakamura T; Itano T; Nishiyama A; Nagai Y; Shiraga F
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4099-110. PubMed ID: 22661470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.